NIH funding changes threaten Pittsburgh's biomedical research, risking jobs, innovation and future medical breakthroughs, ...
A new initiative rolled out under President Donald Trump’s administration is cutting billions from grants for "indirect costs" tied to biomedical research, such as facilities, equipment and ...
A de facto funding freeze on federal biomedical grants could soon stymie UC Santa Cruz research and stifle the county’s biotech industry, ...
8d
Zacks Investment Research on MSNPuma Biotech (PBYI) Q4 Earnings and Revenues Beat EstimatesPuma Biotech (PBYI) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.31 per share a year ago. These figures ...
ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results